Influence of Haemophilus influenzae beta-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenicillins and second- and third-generation cephalosporins.
García-de-Lomas
J
J
Lerma
M
M
Cebrián
L
L
Juan-Bañón
J L
JL
Coronel
P
P
Giménez
M J
MJ
Aguilar
L
L
D000667:Ampicillin / Q000494:pharmacology*; D000668:Ampicillin Resistance / Q000235:genetics; D002511:Cephalosporins / Q000494:pharmacology*; D006192:Haemophilus Infections / Q000188:drug therapy / Q000382:microbiology*; D006193:Haemophilus influenzae / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D008826:Microbial Sensitivity Tests; D009154:Mutation; D046915:Penicillin-Binding Proteins / Q000235:genetics*; D010641:Phenotype; D013030:Spain / Q000453:epidemiology; D001618:beta-Lactamases / Q000096:biosynthesis
D002511:Cephalosporins; D046915:Penicillin-Binding Proteins; D000667:Ampicillin; D001618:beta-Lactamases